Advance Program | ADA 82nd Scientific Sessions - 21

ADVANCE PROGRAM
* Race, Racism, and Diabetes
Research
Race, Racism, and How We Provide
Care in Diabetes
Marshall Chin, MD, MPH
What Does the Science Tell Us about
Racial Differences in A1C?
Elizabeth Selvin, PhD, MPH
Perpetuating Racism through Diabetes
Research
Arleen M. Tuchman, PhD
How Race Becomes Biology
Clarence Gravlee, PhD
A Critical Appraisal of Diabetes
Research and Race from the Past
Decade
Question and Discussion Period
* Diabetes and Related Diseases-
From Variant to Functional Target
From Gene to Function across Tissues
in Diabetes
Stephen Parker, PhD
Discovery of Functional Targets in
Diabetes and Obesity
Karen L. Mohlke, PhD
Identifying Functional Targets in
Metabolic Disorders
Paivi Pajukanta, MD, PhD
Mechanisms of Gene-to-Function in the
Beta Cell
Suna Onengut-Gumuscu, PhD
* Emerging Approaches to Beta Cell
Replacement for Type 1 Diabetes
Progress in Encapsulation Techniques
Andrew R. Pepper, PhD
Early Clinical Studies using Stem CellDerived
Beta Cells
Islet Xenotransplantation
* Inter-organelle Communication
Lipid Droplets and Metabolic
Dysfunction
Douglas G. Mashek, PhD
Endoplasmic Reticulum-associated
Metabolic Regulation
Deyu Fang, PhD
Inter-organ Crosstalk in Metabolic
Syndrome
Rana K. Gupta, PhD
Golgi-Derived Vesicles Drive
Mitochondrial Division
* Including Sex as a Biological
Variable in Diabetes Research-
State-of-The-Art
NIH Policy on Sex as a Biological
Variable Five years In-Outcomes and
Expectations
Considering Sex as a Biological
Variable Will Require a Global Shift in
Science Culture
Rebecca Shansky, PhD
Sex as a Biological Variable in Preclinical
Research-The Contributions
of Gonadal and Chromosomal Sex-toSex
Differences in Adiposity in Mice
Karen Reue, PhD
Sex as a Biological Variable in Clinical
Research-Influence of Sex and
Gender on Diabetes Complications
Judith G. Regensteiner PhD
* Novel Methodologies for Assessing
Islet Function
Topography of Islets in the Pancreas by
Optical Imaging
Ulf Ahlgren, PhD
iDisco Technology to Assess
Islet Innervation and Human Islet
Engraftment
Alexandra Alvarsson, Postdoc
CODEX Technology and Pancreatic
Islet Imaging in Diabetes
Diane C. Saunders, BS
What's New with Pancreatic Slices
for Ex Vivo in Situ Examination of Islet
Regeneration and Function
Luciana Mateus Goncalves, PhD
* Oral Presentations
SATURDAY, JUNE 4
8:00 a.m.-10:00 a.m.
* Solving the Riddle of Perplexing
Diabetes Foot Topics in Primary
Care
What Drug for This Bug-An Infectious
Disease Primer
Shiwei Zhou, MD
New Approaches in Interventional
Radiology in the Diabetes Limb
Sreekumar Madassery, MD
The Hot Foot-Medical Management
of Acute Charcot Foot
Alton Johnson, DPM
Curious Cutaneous Manifestations of
the Diabetes Foot
Tracey Vlahovic, DPM, FFPM, FCPS
* Reaching Everyone-Health
Disparities and Sex Differences in
Physical Activity
Why Some People Are Less Physically
Active-Disparities in Access
Carlos Crespo, PhD
Walkability Matters-Keeping It in the
Neighborhood to Prevent and Manage
Diabetes
Natalie Colabianchi, PhD
Biological Sex and Ethnicity-Impact
on Physical Training and Activity
Assessment
Siana Jones, PhD
The Menstrual Cycle and Beyond-
Barriers and Facilitators of Activity in
Women with Type 1 Diabetes
Jane E. Yardley, PhD
* Revisiting Beta-Cell Function in
Pregnancy
Physiology of Beta-Cell Function
throughout Pregnancy-Human
Physiology
Camille E. Powe, MD
Molecular Mechanisms of Beta-Cell
Adaptation during Pregnancy
Ronadip R. Banerjee, MD, PhD
Resurgence of Beta-Cell Function in
Type 1 Diabetes-Human Studies and
Potential Mechanisms
Claire L. Meek, MB, ChB, MRCP,
FRCPath, PhD
Genetics of Beta-Cell Function in
Pregnancy-Lessons from Monogenic
Diabetes and Common Genetic
Variants
Soo Heon Kwak, MD, PhD
* NAFLD in Diabetes-An Overlooked
Complication? Diagnosis and
Emerging Therapies
NASH in Diabetes-Epidemiology and
Diagnosis
Kenneth Cusi, MD
Pioglitazone for Management of NASH
Fernando Bril, MD
GLP-1 RA Therapy for Treatment of
NAFLD
Philip Newsome, PhD, MB, ChB, BSc
SGLT2-Inhibitors for Treatment of
NAFLD
Mohammad Shafi Kuchay
Emerging Therapies for NAFLD-
What's in the Pipeline?
Jay D. Horton, MD
HYBRID | NEW ORLEANS | JUNE 3-7, 2022 | #ADA2022
Speakers and presentation titles are subject to change.
21
Advance Program | ADA 82nd Scientific Sessions

Table of Contents for the Digital Edition of Advance Program | ADA 82nd Scientific Sessions
